share_log

Jefferies Downgrades Collegium Pharmaceutical to Hold, Raises Price Target to $37

Jefferies Downgrades Collegium Pharmaceutical to Hold, Raises Price Target to $37

杰富瑞将Collegium Pharmical的评级下调至持有,将目标股价上调至37美元
Benzinga ·  01/04 08:09

Jefferies analyst Glen Santangelo downgrades Collegium Pharmaceutical (NASDAQ:COLL) from Buy to Hold and raises the price target from $30 to $37.

杰富瑞分析师格伦·桑坦杰洛将Collegium Pharmaceutical(纳斯达克股票代码:COLL)的评级从买入下调至持有,并将目标股价从30美元上调至37美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发